Literature DB >> 209216

Genetic analysis of a cytomegalovirus-like agent isolated from human brain.

E S Huang, B Kilpatrick, A Lakeman, C A Alford.   

Abstract

An unusual cytomegalovirus (CMV, strain Colburn) isolated from brain biopsy of a boy with clinical encephalopathy was studied for genetic relatedness to human and simian CMV. Cross-examination of the purified viral DNA by DNA-DNA reassociation kinetics analyses showed more than 90% homology between Colburn virus and simian CMV (strain GR2757) and a lack of detectable homology between Colburn virus and human CMV (strains AD-169 and TW-87). Restriction endonuclease analysis of Colburn DNA showed some similarity of the DNA fragment pattern with that of simian CMV DNA, although the DNA fragment patterns were not identical, and showed no similarity to that of human CMV DNA. The molecular size and density of viral DNA were close to those of simian CMV DNA. The antigenic study, as performed by complement fixation and neutralization tests, showed strong cross-reactivity of Colburn virus to simian GR2757 virus. One-way cross-reaction of Colburn virus to several human CMV isolates (AD-169, Davis, and Town) was detected by complement fixation; this one-way cross-reaction was not obvious in a plaque neutralization test. It was concluded that Colburn is a simian CMV-related virus.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 209216      PMCID: PMC525896     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  14 in total

1.  Experimental infection of marmosets with a cytomegalovirus of human origin.

Authors:  S M Nigida; L A Falk; L G Wolfe; F Deinhardt; A Lakeman; C A Alford
Journal:  J Infect Dis       Date:  1975-11       Impact factor: 5.226

2.  DNA methylases of Hemophilus influenzae Rd. II. Partial recognition site base sequences.

Authors:  P H Roy; H O Smith
Journal:  J Mol Biol       Date:  1973-12-25       Impact factor: 5.469

3.  Antisera to human cytomegaloviruses prepared in the guinea pig: specific immunofluorescence and complement fixation tests.

Authors:  Y T Huang; E S Huang; J S Pagano
Journal:  J Immunol       Date:  1974-02       Impact factor: 5.422

4.  DNA nucleotide sequence restricted by the RI endonuclease.

Authors:  J Hedgpeth; H M Goodman; H W Boyer
Journal:  Proc Natl Acad Sci U S A       Date:  1972-11       Impact factor: 11.205

5.  Human cytomegalovirus. I. Purification and characterization of viral DNA.

Authors:  E S Huang; S T Chen; J S Pagano
Journal:  J Virol       Date:  1973-12       Impact factor: 5.103

6.  New human papovavirus (B.K.) isolated from urine after renal transplantation.

Authors:  S D Gardner; A M Field; D V Coleman; B Hulme
Journal:  Lancet       Date:  1971-06-19       Impact factor: 79.321

7.  Spectrum of human cytomegalovirus complement-fixing antigens.

Authors:  G R Dreesman; M Benyesh-Melnick
Journal:  J Immunol       Date:  1967-12       Impact factor: 5.422

8.  Further studies of a simian virus 40-like virus isolated from human brain.

Authors:  L P Weiner; R M Herndon; O Narayan; R T Johnson
Journal:  J Virol       Date:  1972-07       Impact factor: 5.103

9.  Human cytomegalovirus. II. Lack of relatedness to DNA of herpes simples I and II, Epstein-Barr virus, and nonhuman strains of cytomegalovirus.

Authors:  E S Huang; J S Pagano
Journal:  J Virol       Date:  1974-03       Impact factor: 5.103

10.  Common structural antigen of papovaviruses of the simian virus 40-polyoma subgroup.

Authors:  K V Shah; H L Ozer; H N Ghazey; T J Kelly
Journal:  J Virol       Date:  1977-01       Impact factor: 5.103

View more
  13 in total

1.  Multicomponent origin of cytomegalovirus lytic-phase DNA replication.

Authors:  D G Anders; S M Punturieri
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

2.  Identification and characterization of a major early cytomegalovirus DNA-binding protein.

Authors:  D G Anders; A Irmiere; W Gibson
Journal:  J Virol       Date:  1986-05       Impact factor: 5.103

3.  Application of "Hirt supernatant" DNA to the molecular epidemiology of cytomegalovirus infections.

Authors:  Y Eizuru; S Inagawa; Y Minamishima
Journal:  J Clin Microbiol       Date:  1984-11       Impact factor: 5.948

4.  Cytomegalovirus isolation from a chimpanzee with acute demyelinating disease after inoculation of multiple sclerosis brain cells.

Authors:  Z Wroblewska; D Gilden; M Devlin; E S Huang; L B Rorke; T Hamada; T Furukawa; L Cummins; S Kalter; H Koprowski
Journal:  Infect Immun       Date:  1979-09       Impact factor: 3.441

Review 5.  Simian herpesviruses and their risk to humans.

Authors:  Ryan D Estep; Ilhem Messaoudi; Scott W Wong
Journal:  Vaccine       Date:  2010-05-26       Impact factor: 3.641

6.  Immunological and molecular comparison of simian cytomegaloviruses isolated from African green monkey (Cercopithecus aethiops) and Japanese macaque (Macaca fuscata).

Authors:  Y Eizuru; K Tsuchiya; R Mori; Y Minamishima
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

7.  Initial characterization of four cytomegalovirus strains isolated from chimpanzees. Brief report.

Authors:  B W Swinkels; J L Geelen; P Wertheim-van Dillen; A A van Es; J van der Noordaa
Journal:  Arch Virol       Date:  1984       Impact factor: 2.574

8.  Patterns of divergence in the vCXCL and vGPCR gene clusters in primate cytomegalovirus genomes.

Authors:  Donald J Alcendor; Jianchao Zong; Aidan Dolan; Derek Gatherer; Andrew J Davison; Gary S Hayward
Journal:  Virology       Date:  2009-10-09       Impact factor: 3.616

9.  A cytomegalovirus DNA sequence containing tracts of tandemly repeated CA dinucleotides hybridizes to highly repetitive dispersed elements in mammalian cell genomes.

Authors:  K T Jeang; G S Hayward
Journal:  Mol Cell Biol       Date:  1983-08       Impact factor: 4.272

10.  Polypeptides and major antigens of four new isolates of cytomegalovirus.

Authors:  M I Siqueira-Linhares; N Faucon-Biguet; Y Chardonnet; J P Revillard
Journal:  Med Microbiol Immunol       Date:  1981       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.